Ligand Pharmaceuticals Inc (LGND)
Income Tax Expense
$40.74M
TTM · Period ending: · USD
LGND Income Tax Expense
Latest reported$40.74Mperiod ending
Latest reported$40.74Mperiod ending
LGND Income Tax ($6.20M → $40.74M)
Annual income tax expense
High-resolution chart · PNG
LGND income tax expense history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Income Tax Expense (USD) |
|---|---|
| 34,507,000 | |
| 6,550,000 | |
| 9,841,000 | |
| 41,230,000 | |
| -4,148,000 | |
| -5,306,000 | |
| 167,337,000 | |
| 30,009,000 | |
| 44,675,000 | |
| 10,327,000 | |
| -219,596,000 | |
| 410,000 | |
| 374,000 | |
| -1,191,000 | |
| -13,103,000 | |
| -2,617,000 | |
| -7,924,000 | |
| -55,000 | |
| -18,697,000 | |
| -38,414,000 | |
| 59,000 | |
| 233,000 | |
| 18,284,000 | |
| 8,445,000 | |
| 19,858,000 | |
| 26,494,000 | |
| 18,400,000 | |
| 48,300,000 | |
| 69,400,000 | |
| 4,400,000 | |
| 39,300,000 | |
| 6,200,000 |